Granules India Virginia facility receives FDA EIR approval

Granules India's Virginia manufacturing facility has received an Establishment Inspection Report (EIR) from the US FDA. This approval allows the facility to operate without significant compliance issues and supports the company's API exports to the US market. The EIR is a positive regulatory milestone for the pharma manufacturer's operations.

📊 STOCKS: $GRANULES | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #FDA #Regulatory